About
RESCuing Alkaline Phosphatase
Areas of Focus
Categories
Small Molecule Pharmaceutical
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
3
As Collaborator
2
Total Enrollment
1,313
By Phase
PHASE2/PHASE3: 1EARLY_PHASE1: 1PHASE1/PHASE2: 1PHASE3: 2
By Status
COMPLETED: 4RECRUITING: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT03050476Lead Sponsor
Preventing Systemic Inflammation After Cardiac Surgery With Alkaline Phosphatase
PHASE2/PHASE3Recruiting
1,250 participants
Started: Nov 1, 2017 · Completed: Mar 31, 2026
NCT01889147Collaborator
Microdose and First-In-Human (FIH) Study of Recombinant Human Placental Alkaline Phosphatase (hRESCAP)
EARLY_PHASE1Completed
4 participants
Started: Jun 30, 2013 · Completed: Oct 31, 2013
NCT01416493Lead Sponsor
Bovine Intestinal Alkaline Phosphatase (bIAP) Modulating Rheumatoid Arthritis
PHASE1/PHASE2Completed
6 participants
Started: May 31, 2011 · Completed: Apr 30, 2013
NCT01144611Lead Sponsor
Efficacy and Safety of Bovine Intestinal Alkaline Phosphatase (bIAP) During Heart Surgery
PHASE3Completed
53 participants
Started: Apr 30, 2010 · Completed: Dec 31, 2013
NCT01010724Collaborator
Efficacy and Safety Study on bIAP
PHASE3Completed
Locations (1)
Headquarters
Wageningen, Netherlands
Map
Loading map...